Navigation Links
Isolagen Modifies Ongoing Clinical Program for Acne Scars
Date:11/27/2007

- FDA Recommends Further Analysis of Evaluator Assessment Scale and Photo Guide; Company Proposes Amending Previously Announced Phase III Study as a

Phase II/III Study - - No Impact on Ongoing Pivotal Phase III Clinical Program in Wrinkles -

EXTON, Pa., Nov. 27 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex: ILE) announced today that the Food and Drug Administration (FDA) has provided follow-up on the Phase III program investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. The FDA reiterated that there are no safety issues that would prevent the initiation of the proposed studies. However, the FDA asked the Company to further clarify certain protocol issues and raised questions related to the acne scar Evaluator Assessment Scale and Photo Guide. The FDA recommended that in order to address these issues, the Company should conduct a Phase II study; therefore, the Company will propose modifying the ongoing Phase III Study IT- A-008 as a Phase II/III study (as discussed further below). The FDA requests are specific to the acne scar clinical program and do not impact the Company's ongoing, pivotal Phase III clinical program evaluating the Isolagen Therapy for the treatment of nasolabial folds, or wrinkles.

Isolagen's two randomized, double-blind, placebo-controlled acne scar clinical trials (IT-A-008 and IT-A-009) of approximately 120 patients each were designed and powered as Phase III studies. Based on this additional information from the FDA, Isolagen will propose to modify the initiated study IT-A-008 to be a Phase II/III study. This study, which is designed to demonstrate efficacy, will be amended to allow for a closer assessment of the Evaluator Assessment Scale and Photo Guide. Based on the study's findings, the Company will propose to continue with the acne scar pivotal clinical program during 2008. Isolagen believes that the two trials may have the potential to form the b
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Isolagen, Inc. Postpones Annual Meeting
2. Isolagen Initiates Phase III Clinical Program to Investigate Isolagen Therapy(TM) for the Treatment of Acne Scars
3. CNS Response, Inc. Modifies rEEG(SM) Trial Protocol for Treatment-Resistant Depression Study
4. Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids
5. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Clinical depression linked to abnormal emotional brain circuits
8. Preclinical study suggests organ-transplant drug may aid in lupus fight
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Good Clinical Practice Journal Awards: Winners Announced
11. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Swedish study shows that adolescents who suffer from sleep ... to succeed academically compared to those who enjoy a ... in the journal Sleep Medicine . , In ... between 12 and 19 from Uppsala County, researchers from ... habitual short sleep duration (less than 7 hours per ...
(Date:9/23/2014)... San Jose, California (PRWEB) September 23, 2014 ... – Medical transcription is the process of translating ... assessment, clinical course, therapeutic procedures, and prognosis, into ... health insurance agents, patients, and healthcare providers. With ... documentation of each patient’s condition, outsourcing of such ...
(Date:9/23/2014)... If you or a loved one ... treatment may be a challenge. Fortunately, an inventor from ... is designed to improve the experience. , He developed ... having to remove, tear or reposition their clothing. Furthermore, ... their dignity. At the same time, it safeguards their ...
(Date:9/23/2014)... be able to grow enough food there to maintain ... food in NASA,s Orion spacecraft on the year-long trip ... extreme conditions? These are questions scientists are trying to ... International Space Station (ISS). , Plant biology investigations called ... to adapt to a microgravity environment. When a crew ...
(Date:9/23/2014)... allow electrical signals to pass unhindered through new ... Texas Children,s Hospital. , A team led by ... Matteo Pasquali created the patches infused with conductive ... a sponge-like bioscaffold that contains microscopic pores and ... overcome a limitation of current patches in which ...
Breaking Medicine News(10 mins):Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 2Health News:Expanding Healthcare Sector Drives Demand for Medical Transcription Services, According to New Report by Global Industry Analysts, Inc. 3Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2Health News:Getting to the root of the problem in space 2Health News:Getting to the root of the problem in space 3Health News:Getting to the root of the problem in space 4Health News:Nanotubes help healing hearts keep the beat 2Health News:Nanotubes help healing hearts keep the beat 3
... revolutionary EnviroCool fresh air cooling system also ... air pollution, WINCHESTER, Calif., June 11 With ... on the rise, homeowners around the,country are turning to ... cool their homes: QuietCool and EnviroCool., The QuietCool ...
... HMS Holdings Corp. (Nasdaq:,HMSY) today announced that it will ... held June 24-26, 2008 in New York,City., Walter ... Corp.,will present on Tuesday, June 24th at 10:15 am ... presentation can be accessed through,our website at http://www.hmsholdings.com/news/presentations.asp ...
... Research Group, offering hope to sufferers of asbestos-related ... today. , Special guest Karen Banton, widow of ... the group, saying: , "Today brings hope of ... asbestos exposure and ultimately a future free of ...
... Award Presented to QualityMetric Employee at Annual ... ... 11 In recognition of clinical,research to improve the understanding ... Senior Scientist with,QualityMetric(TM) Health Outcomes Solutions, was presented the 2008-2009,American ...
... Patient Share by 2012, According to a ... New Report from Decision Resources, ... the,world,s leading research and advisory firms focusing on pharmaceutical and,healthcare ... of,fistulas in a greater percentage of patients than,Centocor/Schering-Plough/Mitsubishi Tanabe,s Remicade ...
... in children may have an impact on cardiovascular functioning ... according to a research abstract that will be presented ... the Associated Professional Sleep Societies (APSS). , The study, ... of Melbourne and Monash University, Melbourne, Victoria, Australia, focused ...
Cached Medicine News:Health News:A Far Less Expensive, Green Alternative to Traditional Air Conditioning, from QuietCool 2Health News:New research group offers hope to asbestosis sufferers 2Health News:New research group offers hope to asbestosis sufferers 3Health News:QualityMetric Senior Scientist Min Yang, MD, PhD, Recipient of Prestigious Clinical Research Award in Women's Health 2Health News:QualityMetric Senior Scientist Min Yang, MD, PhD, Recipient of Prestigious Clinical Research Award in Women's Health 3Health News:A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market 2Health News:Primary snoring in children impacts cardiovascular functioning 2Health News:Primary snoring in children impacts cardiovascular functioning 3
(Date:9/23/2014)... CHICAGO , Sept. 23, 2014  Hill-Rom (NYSE: ... agreement with Providence Health ( Renton, WA ... new agreement expands the companies, existing relationship as Hill-Rom ... Maternal, and Bariatric capital bed frame and surface products. ... largest health systems in the U.S.  It operates 34 ...
(Date:9/23/2014)... , Sept. 23, 2014 Research ... "Biopharmaceutical and Vaccine Production Markets" report to ... many new therapies and vaccines - including products to ... are still huge challenges during the final stages of ... when and how to risk production capital to upscale ...
(Date:9/23/2014)... 23, 2014 Rising health ... and increasing number of foreign and domestic players in ... India   The ... most high growth potential markets worldwide due to multiple ... among the youth, changing food consumption patterns, increasing diabetic ...
Breaking Medicine Technology:Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2Biopharmaceutical and Vaccine Production Markets 2Biopharmaceutical and Vaccine Production Markets 3India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3
... 10th Annual Superbugs and Superdrugs Conference on ... ... 10 Enanta Pharmaceuticals, a,leader in the development of small ... program to,evaluate a new macrolide-related drug class, Bicyclolides, in the ...
... - Strategic Collaboration with the National Cancer Institute,s NABTT ... ... 10 BiPar Sciences, Inc. today,announced the expansion of the clinical ... the most,common glioma in adults. BSI-201, the first poly ADP-ribose polymerase,(PARP) ...
Cached Medicine Technology:Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 3BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer 2
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
Thermal Cautery, Sterile Single-Use Units for Vasectomy. Burns at approximately 1200C (2200 F). Integrated unit includes handle, vasectomy tip, & AA batteries. Box of 10 units. Discounts on 2 or more...
Non-Cantilevered Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring diameter approximately 3.0 mm....
... earmolds add comfort and enhance hearing abilities ... paramedics, Flight-for-Life helicopter personnel, emergency technicians and ... specific in design and can be fabricated ... in today's industry to ensure clear sound ...
Medicine Products: